How Monogram Health plans to use its new $160 million round of funding
June 10, 2021 at 15:36 PM EDT
Through evidence-based data analytics, Frist said it’s now possible to identify early-stage patients with kidney disease, much the way his previous company, Aspire Health, did in identifying patients that would need palliative care.